Remnant epitopes, autoimmunity and glycosylation.
The role of extracellular proteolysis in innate and adaptive immunity and the interplay between cytokines, chemokines and proteinases are gradually becoming recognized as critical factors in autoimmune processes. Many of the involved proteinases, including those of the plasminogen activator and matr...
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2006
|
| _version_ | 1797102208230096896 |
|---|---|
| author | Opdenakker, G Dillen, C Fiten, P Martens, E Van Aelst, I Van den Steen, P Nelissen, I Starckx, S Descamps, F Hu, J Piccard, H Van Damme, J Wormald, M Rudd, P Dwek, R |
| author_facet | Opdenakker, G Dillen, C Fiten, P Martens, E Van Aelst, I Van den Steen, P Nelissen, I Starckx, S Descamps, F Hu, J Piccard, H Van Damme, J Wormald, M Rudd, P Dwek, R |
| author_sort | Opdenakker, G |
| collection | OXFORD |
| description | The role of extracellular proteolysis in innate and adaptive immunity and the interplay between cytokines, chemokines and proteinases are gradually becoming recognized as critical factors in autoimmune processes. Many of the involved proteinases, including those of the plasminogen activator and matrix metalloproteinase cascades, and also several cytokines and chemokines, are glycoproteins. The stability, interactions with inhibitors or receptors, and activities of these molecules are fine-controlled by glycosylation. We studied gelatinase B or matrix metalloproteinase-9 (MMP-9) as a glycosylated enzyme involved in autoimmunity. In the joints of rheumatoid arthritis patients, CXC chemokines, such as interleukin-8/CXCL8, recruit and activate neutrophils to secrete prestored neutrophil collagenase/MMP-8 and gelatinase B/MMP-9. Gelatinase B potentiates interleukin-8 at least tenfold and thus enhances neutrophil and lymphocyte influxes to the joints. When cartilage collagen type II is cleaved at a unique site by one of several collagenases (MMP-1, MMP-8 or MMP-13), it becomes a substrate of gelatinase B. Human gelatinase B cleaves the resulting two large collagen fragments into at least 33 peptides of which two have been shown to be immunodominant, i.e., to elicit activation and proliferation of autoimmune T cells. One of these two remnant epitopes contains a glycan which is important for its immunoreactivity. In addition to the role of gelatinase B as a regulator in adaptive immune processes, we have also demonstrated that it destroys interferon-beta, a typical innate immunity effector molecule and therapeutic cytokine in multiple sclerosis. Furthermore, glycosylated interferon-beta, expressed in Chinese hamster ovary cells, was more resistant to this proteolysis than recombinant interferon-beta from bacteria. These data not only prove that glycosylation of proteins is mechanistically important in the pathogenesis of autoimmune diseases, but also show that targeting of glycosylated proteinases or the use of glycosylated cytokines seems also critical for the treatment of autoimmune diseases. |
| first_indexed | 2024-03-07T06:02:42Z |
| format | Journal article |
| id | oxford-uuid:ecc1414e-9bf7-4e04-b337-397b1a07f5c0 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T06:02:42Z |
| publishDate | 2006 |
| record_format | dspace |
| spelling | oxford-uuid:ecc1414e-9bf7-4e04-b337-397b1a07f5c02022-03-27T11:19:55ZRemnant epitopes, autoimmunity and glycosylation.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:ecc1414e-9bf7-4e04-b337-397b1a07f5c0EnglishSymplectic Elements at Oxford2006Opdenakker, GDillen, CFiten, PMartens, EVan Aelst, IVan den Steen, PNelissen, IStarckx, SDescamps, FHu, JPiccard, HVan Damme, JWormald, MRudd, PDwek, RThe role of extracellular proteolysis in innate and adaptive immunity and the interplay between cytokines, chemokines and proteinases are gradually becoming recognized as critical factors in autoimmune processes. Many of the involved proteinases, including those of the plasminogen activator and matrix metalloproteinase cascades, and also several cytokines and chemokines, are glycoproteins. The stability, interactions with inhibitors or receptors, and activities of these molecules are fine-controlled by glycosylation. We studied gelatinase B or matrix metalloproteinase-9 (MMP-9) as a glycosylated enzyme involved in autoimmunity. In the joints of rheumatoid arthritis patients, CXC chemokines, such as interleukin-8/CXCL8, recruit and activate neutrophils to secrete prestored neutrophil collagenase/MMP-8 and gelatinase B/MMP-9. Gelatinase B potentiates interleukin-8 at least tenfold and thus enhances neutrophil and lymphocyte influxes to the joints. When cartilage collagen type II is cleaved at a unique site by one of several collagenases (MMP-1, MMP-8 or MMP-13), it becomes a substrate of gelatinase B. Human gelatinase B cleaves the resulting two large collagen fragments into at least 33 peptides of which two have been shown to be immunodominant, i.e., to elicit activation and proliferation of autoimmune T cells. One of these two remnant epitopes contains a glycan which is important for its immunoreactivity. In addition to the role of gelatinase B as a regulator in adaptive immune processes, we have also demonstrated that it destroys interferon-beta, a typical innate immunity effector molecule and therapeutic cytokine in multiple sclerosis. Furthermore, glycosylated interferon-beta, expressed in Chinese hamster ovary cells, was more resistant to this proteolysis than recombinant interferon-beta from bacteria. These data not only prove that glycosylation of proteins is mechanistically important in the pathogenesis of autoimmune diseases, but also show that targeting of glycosylated proteinases or the use of glycosylated cytokines seems also critical for the treatment of autoimmune diseases. |
| spellingShingle | Opdenakker, G Dillen, C Fiten, P Martens, E Van Aelst, I Van den Steen, P Nelissen, I Starckx, S Descamps, F Hu, J Piccard, H Van Damme, J Wormald, M Rudd, P Dwek, R Remnant epitopes, autoimmunity and glycosylation. |
| title | Remnant epitopes, autoimmunity and glycosylation. |
| title_full | Remnant epitopes, autoimmunity and glycosylation. |
| title_fullStr | Remnant epitopes, autoimmunity and glycosylation. |
| title_full_unstemmed | Remnant epitopes, autoimmunity and glycosylation. |
| title_short | Remnant epitopes, autoimmunity and glycosylation. |
| title_sort | remnant epitopes autoimmunity and glycosylation |
| work_keys_str_mv | AT opdenakkerg remnantepitopesautoimmunityandglycosylation AT dillenc remnantepitopesautoimmunityandglycosylation AT fitenp remnantepitopesautoimmunityandglycosylation AT martense remnantepitopesautoimmunityandglycosylation AT vanaelsti remnantepitopesautoimmunityandglycosylation AT vandensteenp remnantepitopesautoimmunityandglycosylation AT nelisseni remnantepitopesautoimmunityandglycosylation AT starckxs remnantepitopesautoimmunityandglycosylation AT descampsf remnantepitopesautoimmunityandglycosylation AT huj remnantepitopesautoimmunityandglycosylation AT piccardh remnantepitopesautoimmunityandglycosylation AT vandammej remnantepitopesautoimmunityandglycosylation AT wormaldm remnantepitopesautoimmunityandglycosylation AT ruddp remnantepitopesautoimmunityandglycosylation AT dwekr remnantepitopesautoimmunityandglycosylation |